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Abstract
Background: Current (1999) World Health Organization guidelines recommend giving routine antibiotics (AB) for all
children with severe acute malnutrition (SAM), even if they have uncomplicated disease with no clinically obvious infections.
We examined the evidence behind this recommendation.
Methods and Findings: OVID-MEDLINE, EMBASE, COCHRANE, GLOBAL-HEALTH, CINAHL, POPLINE, AFRICA-WIDE-NiPAD,
and LILACS were searched for AB efficacy, bacterial resistance, and infection rates in SAM. Following PRISMA guidelines, a
systematic review and meta-analysis were performed. Three randomised controlled trials (RCT), five Cochrane reviews, and
37 observational studies were identified. One cohort-study showed no increase in nutritional-cure and mortality in
uncomplicated SAM where no AB were used. (p.0.05). However, an unpublished RCT in this setting did show mortality
benefits. Another RCT did not show superiority of ceftriaxone over amoxicilllin for these same outcomes, but adressed SAM
children with and without complications (p = 0.27). Another RCT showed no difference between amoxicillin and
cotrimoxazole efficacies for pneumonia in underweight, but not SAM. Our meta-analysis of 12 pooled susceptibility-studies
for all types of bacterial isolates, including 2767 stricly SAM children, favoured amoxicillin over cotrimoxazole for
susceptibility medians: 42% (IQR 27–55%) vs 22% (IQR 17–23%) and population-weighted-means 52.9% (range 23–57%) vs
35.4% (range 6.7–42%). Susceptibilities to second-line AB were better, above 80%. Prevalence of serious infections in SAM,
pooled from 24 studies, ranged from 17% to 35.2%. No study infered any association of infection prevalence with AB
regimens in SAM.
Conclusions: The evidence underlying current antibiotic recommendations for uncomplicated SAM is weak. Susceptibility-
studies favour amoxicillin over cotrimoxazole. However, given that these antibiotics have side-effects, costs, and risks as well
as benefits, their routine use needs urgent testing. With reliable monitoring, we believe that there is sufficient equipoise for
placebo controlled RCTs, the only robust way to demonstrate true efficacy.
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Introduction
Severe Acute Malnutrition (SAM) affects nearly 20 million
children under five, and contributes to one million child deaths
yearly [1,2]. SAM is an important co-factor of severe infections.
Associated with immune-deficiency and respiratory muscle atro-
phy, SAM triples the risk of mortality from pneumonia, measles,
or diarrhoea [1,3], SAM as defined in the WHO-UNICEF joint
statement includes two entities: severe wasting and nutritional
oedema [2,4,5,6,7]. Severe wasting (marasmus), is defined as
weight-for-height (WH) below 23 standard deviations (SD or Z-
scores), or MUAC (middle upper arm circumference) ,115 mm
[2,4,5,6,7]. Nutritional oedema (Kwashiorkor) is defined by
bilateral pitting oedema, independently of WH.
The 1999 World Health Organization (WHO) SAM manage-
ment guidelines focused on inpatients aged 6–59 months, and
progressively evolved into Community based Management of
Severe Acute Malnutrition (CMAM) [7], acknowledged by WHO,
UNICEF and partners in their 2007–2009 statements [2,6,7,8].
Current recommendations for giving routine antibiotics (AB) arose
from the time when all children with SAM were treated as
inpatients [5].However this recommendation was carried-over into
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the new outpatient subgroup [2], those with ‘‘uncomplicated
SAM’’, without a specific risk/benefit evaluation.
By definition, uncomplicated SAM children aged 6–59 months
present no fever, no sign of infection, nor complicated disease
according to IMCI (Integrated Management of Childhood
Disease) [9,10]; they also need to present a sufficiently good
appetite to eat a standard amount of Ready-to-Use-Therapeutic-
Food (RUTF appetite test); they are treated as low-risk outpatient
and comprise about 80% of SAM children [5]. The AB is given for
5–7 days during the first week of the 6–12 weeks outpatient
nutritional treatment.
Significant improvements in coverage and mortality were
achieved by CMAM [2,6,8,11], but the AB strategy was not
adapted. It was impossible to establish benefits attributable to AB:
therefore children with uncomplicated SAM still receive AB [6,7].
Experience from inpatient-based SAM treatment programmes
suggested that AB improve survival [12], by treating underlying
bacterial complications, possibly undetectable (no fever or
tachycardia) in very emaciated bradycardic or hypothermic
children [5]. Although AB are part of most guidelines, there has
been little analysis of evidence behind the current practice of
giving 5–7 days of amoxicillin (AMX) or cotrimoxazole (CTX), in
complicated or uncomplicated SAM. These first-line AB are also
called ‘‘routine’’ or ‘‘systematic’’ AB, whereas second-line intra-
venous AB, are given for serious complications. We shall discuss
the appropriateness of the first-line AB only.
Regarding the choice of AB, broad-spectrum AB were initially
suggested [13],[14], combining standard highly fortified diets oral
with AMX, CTX or Metronidazole(MTZ), as first line, or second
line injectable Ampicillin (AMP) plus Gentamycin (GEN), plus
antimalarials, deworming agents, vitamin A, folate and micronu-
trients. Treatments showed excellent results on mortality [15], but
antibiotic-attributable survival was not studied. AMX is more
effective against some bacteria (Streptococcus, Haemophilus, and
Enterococci) whereas CTX is more effective against others
(Staphylococcus, E.coli, Salmonella, and Shigella), but which
bacteria cause more complications in SAM remains unclear.
Reasons to reassess AB in uncomplicated SAM were: high
bacterial resistances causing low AB efficacy; low proportions of
infections in uncomplicated SAM; added cost and complexity;
possible excessive toxicity and allergic reactions. Several million
children would be affected by a change of policy.
Our aim was to assess the appropriateness and efficacy of
routine first-line antibiotics, AMX and CTX, for children aged 6–
59 months with uncomplicated SAM.
Methods
Search Strategy
PRISMA guidelines for systematic reviews and meta-analyses
were used [16]. We compared international organisations
guidelines on antibiotics in SAM. The systematic review addressed
the question: ‘‘Do children with uncomplicated Severe Acute
Malnutrition need antibiotics?’’. Sub-questions were: clinical
efficacy of AB in SAM; bacterial susceptibilities to AB in SAM;
prevalence of infections in SAM according to AB given. Boolean
operators and Medical Subject Headings (MESH) were used,
through eight databases from January 1960 to August 2011:
OVID-MEDLINE, EMBASE, COCHRANE, GLOBAL
HEALTH, CINAHL, POPLINE, AFRICA-WIDE-NiPAD, LI-
LACS. We searched articles in English, French, Spanish,
Portuguese, and German, and translations from other languages
(Chinese, Japanese, and Korean). No geographical limits were
applied. We applied inclusion and exclusion criteria by sub-
questions and designs. There was no study protocol or registration
number. All PRISMA steps were used, including checklist (File
S1), and search results flowchart (Figure 1).
Selection Criteria
Guidelines. Published by international organisations.
Studies. Cochrane reviews, randomised controlled trials
(RCT), and observational studies on retrospective efficacy (cohort),
bacterial AB susceptibilities, bacterial infections in SAM.
Participants (inclusions). Age 6–59 months, plus 0–15
years for possible indirect evidence. Case definitions: SAM
children aged 6–59 months with a WH,23 Z-score and/or
bilateral pitting oedema (all references) and/or WH,70% of
median and/or MUAC,110 mm (NCHS/WHO 1977 referenc-
es) and/or MUAC,115 mm (WHO 2006 growth standards) [4].
Marasmus (Severe wasting): WH,23 Z-score (or ,70% of
median before 2006), or MUAC,115 mm (,110 mm before
2006). Kwashiorkor: children presenting bilateral pitting oedema,
whatever their WH and MUAC, immediately classified as SAM.
Uncomplicated SAM=SAM children with successful standard
appetite test, without fever, clinical infections, or complications
defined by IMCI, treated as outpatient by the lowest health system
level, usually a health centre.
Complicated SAM=SAM cases without appetite and/or with
medical complications (IMCI definitions), treated as inpatients in a
hospital setting.
Outcomes. AB efficacy was defined as a measure of effect
such as odds ratios, risk ratios, or risk reduction% in the following
endpoints: case-fatality-rate (CFR), recovery rate, nutritional cure
(commonly defined as reaching a weight-for-height within normal
range: $80% of median or $22 Z-scores), infection incidence
(bacteraemia, sepsis, pneumonia, urinary tract infections, menin-
gitis, and diarrhoea), AB susceptibility/resistance.
Exclusions. Congenital malformations and chronic diseases,
except HIV and TB. No study was excluded due to imprecise
calculations of efficacy or measures of effect.
Search strategy
Search terms: 1) Malnutrition (malnourish*/wast*/undernutri-
tion/undernourished/marasm*/kwashiorkor), 2) Child (pediat-
ric*/paediatric*/infant*/toddler*/newborn), 3) Antibiotic prophy-
laxis/sensitivity/resistance/antibiotic.mp), amoxicillin (amoxi*/
ampicillin/penicillin/clamoxyl) 4) Cotrimoxazole (Bactrim/Cotrim/
Septrin/Trimethoprim-Sulphamethoxazole), and combinations
1+2+3, 1+2+4, 1+2+3+4. After a first search finding few quan-
titative studies, we added search terms: ‘‘infection* or bacterae-
mia* or sepsis or septic*’’.
Data collection and analysis
Results were classified by study type, outcome, relevance
(exclusively SAM or not), and age. When possible, results were
pooled together. Studies with similar inclusion criteria were
eligible for Meta-analysis. Odds ratio (OR) with 95% confidence
intervals (95%CI) were the measure of effect for RCT. Suscep-
tibility to AB were summarised as medians with 25–75-inter-
quartile ranges (IQR), and means weighted according to number
of subjects (N), and pooled (coefficient proportional to N of each
study) into meta-analyses of observational studies [17], using
Microsoft ExcelTM 2007 and STATATM10.1 (StataCorp, Texas,
USA). Forest-plots were not applicable due to absence of
comparable measures of effect (OR), so only observational data
were meta-analysed.
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GRADE framework
Evidence quality was evaluated through the GRADE frame-
work [18], qualifying studies as good, moderate, low, or very low
GRADE with ranks points : RCT initially ranked ‘‘good’’
(4 points), and observational studies as ‘‘low’’ (2), but each study
is further assessed: 21 for inconsistency, 21/22 for (serious)
limitations, 21 for bias, 21/22 for (major) uncertainty. It is
increased +1 for strong associations, no plausible confounders,
direct evidence (such as adherence to efficacy criteria), +2 for no
major validity threats, and +1 for dose-response.
Results
The review of guidelines is summarized in File S2: it showed
several differences for the 2 types of first-line AB (AMX and
CTX): five different dosages (CTX 4 or 5 mg/kg/d; AMX 50–100
or 70–100 mg/kg/day or three weight-classes) and two different
durations (5 or 7 days). Second-line AB are also shown, and
highlight guideline diversity [5,8,19,20,21,22].
Figure 1 shows the systematic review search flowchart and
numbers of articles. From eight databases, 2772 titles were found,
ranging from 15 (LILACs) to 1304 (EMBASE) excluding
duplicates. After reading titles, only 326 abstracts were included.
Figure 1. Search results on PRISMA Flowchart (Preferred Reporting Items for Systematic Reviews and Meta-Analyses).
doi:10.1371/journal.pone.0053184.g001
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Narrowing to quantitative data on AB efficacy, AB susceptibility,
and infection prevalence, 45 articles were included: three RCT,
five Cochrane reviews, and 37 observational studies.
The data obtained were included in Table 1 for randomised
trials, Cochrane reviews, and a cohort efficacy study, and
Tables 2 and 3 for observational studies on bacterial resistance
and infection prevalence respectively. Due to heterogeneity in
inclusion criteria (SAM, age, and AB) a meta-analysis of
intervention studies was impossible. A meta-analysis of observa-
tional data was conducted.
Randomised trials and other effectiveness studies
Two studies directly addressed our research question: a
retrospective cohort-study in Malawi [23]: it compared two
therapeutic feeding programs for children 6–59 months with
uncomplicated SAM (WH,23Z), one using AMX for 7 days at
60 mg/kg/day (n= 498), and the other using no AB (n = 1955). It
showed worse recovery rates at four weeks in the AMX group
(40% vs. 71%), and no evidence of superiority of AMX over the
no-antibiotic group at 12 weeks (84% vs. 86%). However these two
cohorts were located in two separate districts, and data were
collected retrospectively, two major risks of bias. Levels of height
and weight for age were lower in the amoxicillin group. Whilst
statistical adjustments were made for minor baseline differences in
age and anthropometry, unknown confounding or selection bias
cannot be excluded, and caution is thus needed interpreting this
data.
In contrast, a new RCT in Malawi comparing AMX versus
placebo and an oral cephalosporin (Cefdinir) in uncomplicated
SAM is published by the FANTA organisation on their website
and preliminary non-peer reviewed results suggest superiority of
antibiotics over placebo for outcomes such as survival ( ) and
nutritional cure () [24].
This highly powered (n= 2767) three-arm RCT shows superi-
ority of Cefdinir over Amoxicillin, and Amoxicillin over Placebo
(Table 1), showing significantly improved nutritional recovery at
12 wks (90.9%, 87.7%, 85.1% respectively), and mortality (4.1%,
4.8%, 7.4%).
However, it includes 188 children tested HIV-positive, 388
children of HIV-positive mothers, and about 60% of all children
had presented fever within the past two weeks. Although children
were classified as strictly ‘‘uncomplicated ‘‘(no fever, no visible
complications) it suggests that the infectious risk was high in this
HIV endemic area of Malawi. Effect of Antibiotics was not studied
in the HIV-negative subgroup. Only one published RCT
compared two AB in SAM in a lower HIV area (Sudan): it was
randomized but not blinded, nor placebo-controlled, nor outpa-
tient-based, and was underpowered to assess mortality (n = 458)
[25]. However, this RCT showed that AMX given 5 days orally
was not inferior to intramuscular Ceftriaxone (CRO) given 2 days
on SAM recovery-rates.
Three more RCTs and three Cochrane reviews showed less
direct evidence for comparison of AB in SAM: they analysed the
effectiveness of AB in severe infections (Pneumonia, Measles, and
HIV) in populations with high SAM percentages. For paediatric
pneumonia, AMX showed equivalent (p = 0.16) [26], or slightly
higher recovery rates [OR= 1.33 (1.05–1.67)] compared to
CTX [27]. Among children with Measles [28], AB given
empirically significantly reduced the incidence of pneumonia,
tonsillitis, and purulent otitis media [28,29]. Finally, among HIV
children with a SAM prevalence of 22%, CTX reduced
substantially the general mortality and non-Pneumocystis pneu-
monia rates [30,31].
Among these published RCT and meta-analyses, populations
were so heterogeneous for presence of uncomplicated SAM, age,
and antibiotics types, that meta-analyses were impossible. Table 1
shows the three studies that directly evaluate antibiotics in SAM,
and it shows three contrasting results: 1) AB not superior to no-AB
[23]; 2) CEF superior to AMX and AMX superior to placebo [24];
3) CEF not superior to AMX [25]. None of these studies provided
stratified analyses for HIV+ SAM children.
Bacterial resistance studies
Data on AB in-vitro susceptibility were analysed to infer possible
in-vivo effectiveness. Although these resistance studies are hospital-
based, the vast majority of infections are community-acquired e.g.
1590 community- vs 212 hospital-acquired pathogens in one study
in Kenya [32]: thus the analysed studies reflected the situation of
complicated-SAM children admitted from the community.
Our meta-analysis of observational data from 12 AB resistance
studies using bacterial cultures (blood, urine, cerebrospinal fluid) in
SAM [33–40], and not only SAM children [35,41,42,43], is shown
Table 1. Efficacy of Antibiotics for Severe Acute Malnutrition and paediatric severe infections in efficacy studies (two RCTs and one
cohort).
Author,
Country, Year
Antibiotics
Compared
Design Inclusion
(SAM, HIV) N, Age(m) Effect Measure Grade/Relevance
Trehan [23].
Malawi, 2010
AMX vs No AB Retrospective Cohort: 2
centres only;
Uncomplicated
SAM (all); HIV%= ?
n1:498 n2:1955,
6–59 mths
Recovery worse at 4 wks in AMX group
vs no-AMX (40% vs 71%); No difference
in recovery at 12 wks (84% vs 86%)
p.0.05; Risk of bias due to design
and baseline weight+age differences.
2/High
Manary [24],
Malawi, 2011
Cefdinir (CEF)
vs AMX vs
Placebo
Randomized double-
blinded placebo-controlled:
Uncomplicated SAM (all);
HIV+= 188; Tested = 874
(21.5%); Mother HIV = 388
2767, 6–59 mths Superiority CEF.AMX *.placebo**;
Nutritional recovery at 12 wks: 90.9%,
87.7%, 85.1% p* = 0.02 p** = 0.001;
Mortality: 4.1%, 4.8%, 7.4% (p = .003);
Shorter time to recovery; Risk of BIAS:
HIV-NEG not analysed separately.
4/High (But still not in
peer-reviewed journal)
Dubray [25],
Sudan, 2008
Ceftriaxone (CRO)
vs (2days-IM) AMX
(5days-Oral)
RCT non-blinded:
Complicated &
uncomplicated SAM;
HIV%= ?
458, 6–59 mths No difference in Cured: AMX:70%/CRO:
74.6% (p = 0.27); Mortality:
AMX3.9%/CRO3.1% (p = 0.67). Cost:
0.2 vs 1.6 Euros (10 kg child); Risk of Bias:
complicated SAM included+low power.
3/Medium
doi:10.1371/journal.pone.0053184.t001
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in Table 2: among SAM and non-SAM children, our pooled
mean susceptibilities were equivalent for AMX and CTX, at 53.5
and 55.5% respectively. Berkley et al. showed in a large Kenyan
sample (n = 11’847) that AMX and CTX susceptibilities were
quite similar (59% vs 54%) [35]. However our meta-analysis of
12 pooled susceptibility-studies for all types of bacterial isolates,
including 2767 stricly SAM children, favoured amoxicillin over
cotrimoxazole for susceptibility medians 42% (IQR 27–55%) vs
22% (IQR 17–23%) and population-weighted-means 52.9%
(range 23–57%) vs 35.4% (range 6.7–42%). More resistances to
CTX were observed, but there was no association of resistance
with mortality, whereas resistance was associated with higher age
[35]. CHL and AMX-Clavulanate susceptibilities were respec-
tively 73.7% and 30.7% in SAM. The four antibiotics with lower
resistances (susceptibilities .80%) were: GEN, AMX-GEN,
CRO, and CIP. These aggregated data, reflected the generally
high resistances to AB in a population of mixed, moderate and
severely malnourished children, in Sub-Saharan Africa and
Turkey.
In summary, cultured bacteria in SAM-children showed very
high resistances to first-line AB, such as AMX and CTX.
Infection and microbial prevalence
The prevalence of clinical infections by syndromes were
analysed with regards to the age, country, the HIV prevalence,
and the mortality, and subdivided in 2 groups: Table 3 shows 16
studies of only SAM children [34,38,39,40,44–56], and eight
studies of children with not only SAM (Mixed-NUT)
[37,41,57,58,59,60,61], where percentage of SAM was included.
A total of 21,977 children were included. HIV prevalence was
around 40%. Bacteraemia levels ranged from 3% to 30% (mean:
17%). Mortality varied largely from 18% to 47.4% among SAM,
and 12% to 37.7% among Mixed-NUT. Pneumonia, diarrhoea,
and urinary tract infections (UTI) among SAM-children repre-
sented respectively 33.8%, 35.2% and 24.1%.
Other observational studies added valuable data (not in tables):
the risk of pneumonia doubled (RR=2) among children with
SAM compared to well-nourished [62]. The risk of bacteriuria was
15.2% among SAM vs 1.8% in controls (p,0.01), and UTI 26.6%
vs 5.7% (p,0.05) [63]. Mortality from bacteraemia was 17%, but
doubled with SAM, HIV or TB, and was multiplied by five with
bacterial resistance [58].
A recent prospective observational study among Kenyan
hospitalized SAM children showed the predictive value of a
Table 2. Meta-analysis of observational data on antibiotic (AB) susceptibility (in %) in children with severe acute malnutrition
(SAM) or not only SAM (Mixed-NUT).
Author Country N Age Bacterial antibiotic susceptibility (%)
a
Mths AMX CTX GEN AGE CHL CIP CRO COA
SAM only
Babirekere [33] Uganda 134 6–24 23.3 6.7 33.3 - 60 97 100 -
Bachou (HIV+) [34] Uganda 30 12–24 53 21 78 - 55 93 84 56
Bachou (HIV2) [34] Uganda 39 12–24 31 23 81 - 36 93 90 51
Berkley (SAM subgroup) [35] Kenya 1182 7–35 57 42 - 87 77 - 94 -
Caksen [36] Turkey 31 1–30 - 17 100 - - 82 82 -
Mirabeau [37] Nigeria 203 ,60 - - 85 - - - 61 -
Noorani [38] Kenya 91 ,60 - - 80 - - 80 80 -
Rabasa [39] Nigeria 194 3–60 - 22.7 77 - - - - 22.7
Reed [40] S. Africa 863 ,60 - - - 95.8 - - - -
Median 42 22 80 91.4 57.5 93 84 51
IQR{ 27–55 17–23 77–85 87–96 46–69 82–93 80–94 23–56
Population Weighted* mean (Meta-analysis): 52.9 35.4 72.8 90.7 73.7 90.0 89.3 30.7
Mixed-NUT.f
Bahwere [41] Congo 779 1–16 14.3 79.3 100 - 20.7 - 100 -
Bejon(,14 d) [42] Kenyad 690 ,14 d 28 71 91 76b 81 99 95c -
Bejon (.14 d) [42] Kenyae 690 .14 d 28 39 73 76b 62 99 - -
Berkley (All) [35] Kenya 11847 7–35 59 54 - 88 81 - 93 -
Wolff (UTI) [43] Multiple ,60 12 32 87 - 27 80 67 83
Median 28 54 89 76 62 99 94 83
IQR{ 14–28 39–71 80–96 76–88 27–81 80–99 80–97 -
Population Weighted* mean (Meta-analysis): 53.5 55.5 88.5 86.7 76.7 99.0 93.5 83.0
{IQR: 25–75 inter-quartile range.
*Mean susceptibility weighed proportionally (coefficient) to number of patients (N) per study;
a = Cumulated susceptibilities of all isolated bacteria. Abbreviations: AMX= amoxicillin (or ampicillin), CTX= co-trimoxazol, GEN=Gentamicin, AGE =AMX-GEN
combination, CHL = chloramphenicol (b 91% susceptible to CHL-GEN); CIP =Ciprofloxacin, CRO=Ceftriaxone (c: in this case Cefotaxime instead, similar spectrum);
COA=AMX-Clavulanate combination.
d: age: ,14 days of life,
e: age.14 days of life.
doi:10.1371/journal.pone.0053184.t002
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positive urine dipstick (either Leucocyte esterase or Nitrites) on
mortality (29% vs. 12%, adjusted HR=2.5) [64]. It also showed
high resistances.50% of Coliforms to Cotrimoxazole and
Gentamycin.
We found substantial evidence that Gram-negative bacteria,
Escherichia Coli, non-typhi Salmonella, and other enterobacteriaceae,
represent about 60% (range 58%–77%) and Gram-positive
bacteria, mainly Streptococci and Staphylococci, about 40% of blood-
culture isolates [33,34]. This confirms that children with
complicated SAM need effective second-line antibiotics directly,
rather than AMX or CTX. However there is no evidence about
infection prevalence for uncomplicated SAM outpatients, who (by
definition) have excellent appetite tests, no infectious signs, and are
alert: they have not undergone bacterial studies for ‘‘possibly
undetectable’’ infections.
Grading evidence
With regards to methodology, relevance and generalisability,
following GRADE scoring framework [18], nine studies were
considered high grade but not relevant to our question
[27,28,29,31]. One RCT [24] available online on the FANTA
site, but still not in a peer-reviewed journal qualified as high
GRADE: relevant, high-quality in design (ClinicalTrials
NCT010000298), high power and low bias for the main outcome,
but possibly included some complicated- and HIV-infected SAM
children. One RCT [25] was relevant for SAM but medium grade
due to unblinded randomisation, and lack of separation of
uncomplicated SAM. The 37 observational studies were consid-
ered as moderate, low, or very low quality. Six were considered as
moderate showing strong associations [33,34,35,41,46], low risk of
confounding and bias, clear multivariate analysis of confounders.
The rest of observational studies were low grade. The main
Table 3. Prevalence of HIV, bacteraemia, pneumonia, urinary infections, diarrhoea and mortality, per country, in strictly SAM or not
only SAM (Mixed-NUT) children.
Author Country N Age (m) SAM% HIV+ % BACT % LRTI % UTI % DIARR % CFR %
SAM only
Amadi [44] Zambia 200 6/24 100 54 17
Ashraf [45] Bangladesh 264 6/23 100 35 35
Bachou1 [34] Uganda 450 12/24 100 36.7 17.1
Bachou2 [46] Uganda 315 12/24 100 39.0 18 68 26 38
Banapurmath [47] India 88 ,60 100 32 8 27
Berkowitz [48] S.Africa 68 ,60 100 19* 26 31 18
Berkowitz [49] Review 1346 ,60 100 17.4 22.7 47.4
Christie [50] Jamaica 50 5/23 100 18 24 24 68
Friedland S.Africa 792 ,60 100 7.7**
Jeena [52] S.Africa ,60 100 38
Kala [53] S.Africa 75 ,60 100 34.7
Noorani [38] Kenya 91 ,60 100 43 28.9
Rabasa [39] Nigeria 194 3/60 100 11.3
Reed [40] S.Africa 323 ,60 100 11.8 23
Shimeles [54] Ethiopia 90 4/60 100 36 37
Sunguya [55] Kenya/Tanz. 1121 ,24 100 3 18 8 8
Thame [56] Jamaica 150 1/31 100 10
Pooled 5617 17.0 33.8 24.1 35.2 29.5
Mixed-NUT
Archibald [57] Malawi 229 1/156 8 30 15.3
Bahwere Congo 779 1/16 30 15.9
Berkley [35] Kenya 11847 ,60 10 11 12
Blomberg [58] Tanzania 1828 0/84 16.8 13.9 17
Echave [59] Senegal 114 2/59 15 11
Johnson [60] Nigeria 419 ,60 56.8 10.8
Mirabeau [37] Nigeria 203 ,60 36
Walsh [61] Malawi 2123 ,60*** 28 11.2 17.2 37.7
Pooled 17542 18.2 11 19.4
Overall Mean 23159 17.4 30.6 24.1 35.2 23.7
Abbreviations: BACT: bacteraemia; LRTI = lower respiratory tract infection (Pneumonia); UTI = urinary tract infection; DIARR. = diarrhoea; CFR =mortality/case-fatality-rate.
Oed = oedema. SAM= severe acute malnutrition.
*Bacteraemia cases 6/13 (46%) nosocomial,
**2.2%;
***88% are ,5 yrs (including 43%,1 yr+44% 1–5 yr) and 13% 5–15 yrs.
doi:10.1371/journal.pone.0053184.t003
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limitation was that ‘‘uncomplicated SAM’’ was not addressed
separately.
Discussion
This systematic review found 45 relevant studies, three RCT,
five Cochrane reviews, and 37 observational studies. We
performed a meta-analysis and pooled-analyses that showed
insufficient evidence for current recommendations, and for
choosing the appropriate AB, in uncomplicated SAM, if AB are
really necessary. Our research is the first one focussing on AB in
uncomplicated SAM with a meta-analysis, whereas another very
useful recent review [65] has mainly focussed on second-line AB
and pharmacokinetics without meta-analysis.
The recommendations to give AB systematically present a much
higher level of evidence in case of ‘‘complicated SAM’’ than in
case of uncomplicated SAM. Studies showed high-prevalence and
mortality from bacterial infections in SAM especially with oedema
or HIV. In contrast there is true uncertainty and ‘‘equipoise’’ for
the recommendations in uncomplicated SAM.
Interestingly, one Malawian retrospective cohort study [23],
where one centre gave AMX routinely and another centre did not,
showed some evidence that uncomplicated SAM children can be
successfully renourished without AB, with comparable recovery
rates. However, caution is needed as biases can be substantial in
this retrospective analysis. One large RCT in the same country,
Malawi, published on FANTA’s website (not yet in a peer-
reviewed journal) seems to contradict these first findings, Cefdinir
and AMX showing superior recovery and survival rates than
placebo. [24]. Unfortunately, in both Malawian studies [23,24],
from high HIV-prevalence rural areas, HIV-negative children
were not analysed separately: thus we cannot infer whether
‘‘uncomplicated and HIV-negative’’ SAM children could recover
well without AB.
Less relevant RCTs and Cochrane reviews analysed settings
where uncomplicated and complicated SAM were not distin-
guished: oral AMX given 5 days was not inferior to intramuscular
Ceftriaxone given 2 days for nutritional cure [25]. It suggested that
AMX was still efficacious and that injected Ceftriaxone was not
necessary for the majority of SAM children, of which at least 80%
are uncomplicated [2]. Between first-line AB, AMX efficacy and
resistances did not differ significantly compared to CTX in RCTs
and Cochrane reviews [61], but in our meta-analysis we found less
resistances for AMX than to CTX in bacterial isolates from strictly
SAM children [33,34,35].
There is sufficient evidence that bacterial susceptibilities to
AMX and CTX are low, but our meta-analysis clearly favoured
AMX over CTX for weighted means of AB susceptibility.
Caution is also needed as some studies show good in vivo
effectiveness despite high in vitro resistances [30]. Susceptibilities
are above 80% for most second-line AB, including CIP. CIP can
be given orally and could be considered as first-line in contexts of
high resistances or impossible hospital admission. An oral
cephalosporin (Cefdinir) is being tested in Malawi in a three-arm
RCT against AMX and placebo and could answer our research
question [24].
Our pooled analysis of infection-prevalence from 24 studies
showed about 17% of children with complicated or uncomplicated
SAM presented bacteraemia, and a third presented with
pneumonia, urinary infections, or diarrhoea. Although mortality
was higher in SAM, the prevalence of bacteraemia was very
similar between SAM and non-SAM children: these observational,
mainly cross-sectional data cannot infer causality [35]. We would
need to test outpatients with uncomplicated SAM to answer our
question.
The other limitations of our systematic review were mainly due
to the lack of robust studies to address the research question.
GRADE evaluations showed insufficient relevance to the research
question. Most RCTs had strong internal validity, but lacked
generalisability. Observational studies were closer to the research
question, but presented heterogeneity and inconsistencies There-
fore we minimised the risk of bias of the review as much as
possible: ‘‘Selection bias’’ was reduced by subgrouping similar
studies. Source bias and database biases were minimized by using
a wide range of databases and grey literature sources: LSHTM
library, CAPGAN congress, non peer review or unpublished
randomized trials [24] books and nutrition guidelines. Publication
bias is probably inevitable: we cannot rule out that some research
on SAM demonstrated a benefit of amoxicillin on bacterial gut
overgrowth and nutritional cure, but the articles do not provide
numerical evidence or measures of effect [13].
In conclusion, we found little evidence underpinning current
WHO recommendations for AB in uncomplicated SAM [5],
except for one RCT which shows superiority of AB, in a high-
HIV-prevalence, high-mortality setting . Other RCT and obser-
vational studies suggest equipoise for ‘‘systematic antibiotics vs no
antibiotics’’, and low in vitro AMX and CTX susceptibilities, so
uncertainty remains: it is important to recognise that there are
risks of giving as well as of not giving routine AB. The safety of a
no-antibiotics approach depends on staff ability to correctly
identify complicated SAM. Meanwhile, in areas with weak health
systems, antibiotics could remain a ‘‘safety net’’. In settings with a
stronger health system, not using routine AB saves precious
healthcare resources; decreases the risk of unnecessary side-effects
and adverse effects, and might also delay the development of
bacterial resistance.
With good safety monitoring and carefully selected settings, we
believe that there is sufficient equipoise for placebo controlled
RCTs, the only robust way to demonstrate true efficacy. Future
trials should evaluate antibiotics in uncomplicated SAM in HIV-
negative children and in low-prevalence settings.
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